drug

roluperidone

1 story · latest Aug 7, 2026

Status: Investigational
Code: MIN-101
Trials: 1 registered trial in coverage

Relationships

Developed by Minerva Neurosciences

Timeline

Minerva reports Q2 2026 results, confirms C19 trial timeline for roluperidone

Aug 7Quarterly updateMinerva Neurosciences roluperidone

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.